Serum adiponectin levels in patients with familial mediterranean fever

Protein and Peptide Letters

Volumn 17, Issue 10, 2010, Pages 1258-1262

  Keskin, Göksal ^a   Inal, Ali ^b   Özişik, Lale ^c  

^a DISKAPI YILDIRIM BEYAZIT TRAINING AND RESEARCH HOSPITAL   (Turkey)

^b GULHANE SCHOOL OF MEDICINE   (Turkey)

^c DYBEA Hospital Immunology Department   (Turkey)

Author keywords

Adiponectin; FMF; IL 6

Indexed keywords

ADIPONECTIN; INTERLEUKIN 6;

ADULT; ARTICLE; BLOOD; ENZYME LINKED IMMUNOSORBENT ASSAY; FAMILIAL MEDITERRANEAN FEVER; FEMALE; HUMAN; MALE;

ADIPONECTIN; ENZYME-LINKED IMMUNOSORBENT ASSAY; FAMILIAL MEDITERRANEAN FEVER; FEMALE; HUMANS; INTERLEUKIN-6; MALE; YOUNG ADULT;

EID: 78049320873     PISSN: 09298665     EISSN: None     Source Type: Journal    
DOI: 10.2174/092986610792231555     Document Type: Article

References (46)

1. Önen, F. Familial Mediterranean Fever. Rheumatol. Int., 2006, 26, 489-496.
2. Kiraz, S.; Ertenli, I.; Arici, M.; Çalgüneri, M.; Haznedaroglu, I.; Çelik, I.; Pay, S.; Kirazli, S. Effects of Colchicine on Inflammatory Cytokines and Selectines in Familial Mediterranean Fever. Clin. Exp. Rheumatol., 1998, 16, 721-724.
3. Bevilacqua, M.P.; Nelson, R.M. Selectines. J. Clin. Invest., 1993, 91, 379-387.
4. Onat, A.M.; Özçakar, L.; Uçar, G.; Üreten, K.; Dagli, N.; Kiraz, S.; Ertenli, I.; Çalgüneri, M. Plasma and Platelet Serotonin Levels in Familial Mediterranean Fever. Clin. Exp. Rheumatol., 2007, 25(4), 16-20.
5. Özbalkan, Z.; Öztürk, M.A.; Onat, A.M.; Üreten, K.; Haznedaroglu, I.C.; Kiraz, S.; Ertenli, İ.; Kirazli, S.; Çalgüneri, M. Circulating thrombomodulin levels in familial mediterranean fever. Clin. Exp. Rheumatol., 2006, 24(5), 95-98.
6. Ouchi, N.; Kihara, S.; Funahashi, T.; Matsuzawa, Y.; Walsh, K. Obesity, adiponectin and vascular inflammatory disease. Curr. Opin. Lipidol., 2003, 14, 561-566.
7. Berg, A.H.; Scherer, P.E. Adipose-tissue, inflammation and cardiovascular disease. Circ. Res., 2005, 96, 939-949.
8. Deborah, K.; Theodore, C.; Robert, R.H. Adiponectin in health and disease. Diabetes Obes. Metab., 2007, 9, 282-289.
9. Arita, Y.; Kihara, S.; Ouchi, N. Paradoxical decrease of an adiposespecific protein, adiponectin, in obesity. Biochem. Biophys. Res. Commun., 1999, 257, 79-83.
10. Scherer, P.E.; Williams, S.; Fogliano, M.; Baldini, G.; Lodish, H.F. A novel serum protein similar to C1q, produced exclusively in adipocytes. J. Biol. Chem., 1995, 270, 26746-9.
11. Maeda, K.; Okubo, K.; Shimomura, I.; Funahashi, T.; Matsuzawa, Y.; Matsubara, K. cDNA cloning and expression of a novel adipose-specific collagen-like factor, apM1. Biochem. Biophys. Res. Commun., 1996, 221, 286-289.
12. Shibata, R.; Sato, K.; Pimentel, D.R.; Takemura, Y.; Kihara, S.; Ohashi, K.; Funahashi, T.; Ouchi, N.; Walsh, K. Adiponectin protects against myocardial ischemia-reperfusion injury through AMPK and Cox-2 dependent mechanisms. Nat. Med., 2005, 11, 1096-1103.
13. Bolli, R.; Shinmura, K.; Tang, X.L.; Kodani, E.; Xuan, Y.T.; Guo, Y.; Dawn, B. Discovery of a new function of cyclooxygenase (COX)-2; COX-2 is a cardioprotective protein that alleviates ischemia/reperfusion injury and mediates the late phase of preconditioning. Cardiovasc. Res., 2002, 55, 506-509.
14. Ridker, P.M. High-sensitivity C-reactive protein and cardiovascular risk; rationale for screening and primary prevention. Am. J. Cardiol., 2003, 92, 17-22.
15. Laaksonen, D.E.; Niskanen, L.; Nyyssonen, K.; Punnonen, K.; Tuomainen, T.P.; Valkonen, V.P.; Salonen, R.; Salonen, J.T. Creactive protein and the development of the metabolic syndrome and diabetes in middle-aged men. Diabetologia, 2004, 47, 1403-1410.
16. Wulster-Radcliffe, M.C.; Ajuwon, K.M.; Wang, J.; Christian, J.A.; Spurlock, M.E. Adiponectin differentially regulates cytokines in porcine macrophages. Biochem. Biophys. Res. Commun., 2004, 316, 924-929.
17. Ouchi, N.; Kihara, S.; Arita, Y.; Maeda, K.; Kuriyama, H.; Okamoto, Y. Novel modulator for endothelial adhesion molecules; adipocyte-derived plasma protein, adiponectin. Circulation, 1999, 100, 2473-2476.
18. Livneh, A.; Langevitz, P.; Zemer, D.; Zaks, N.; Kees, S.; Lidar, T.; Migdal, A.; Padeh, S.; Pras, M. Criteria for the diagnosis of familial mediterranean fever. Arthritis Rheum., 1998, 41, 1516-1517.
19. Bagci, S.; Toy, B.; Tüzün, A.; Ates, Y.; Aslan, M.; Inal, A.; Gulsen, M.; Karaeren, N.; Dagalp, K. Continuity of cytokine activation in patientswith familial mediterranean fever. Clin. Rheumatol., 2004, 23, 333-337.
20. Ouchi, N.; Walsh, K. Adiponectin as an anti-inflammatory factor. Clinica Chimica Acta, 2007, 380, 24-30.
21. Weiss, R.; Dziura, J.; Burgert, T.S.; Tamporlane, W.V.; Taksali, S.E.; Yeckel, C.W.; Allen, K.; Lopes, M.; Savoye, M.; Morisson, J.; Sherwin, R.S.; Caprio, S. Obesity and the metabolic syndrome in children and adolescents. N. Engl. J. Med., 2004, 350, 2362-2374.
22. Kubota, N.; Terauchi, Y.; Yamauchi, T.; Kubato, T.; Morio, M.; Matsui, J.; Eto, K.; Yamashita, T.; Kamon, J.; Satoh, H.; Yano, W.; Froguel, P.; Nagai, R.; Kimura, S.; Kadowaki, T.; Noda, T. Distruption of adiponectin causes insulin resistance and neointimal formation. J. Biol. Chem., 2002, 277, 25863-25866.
23. Pischon, T.; Girman, C.J.; Hotamişligil, G.S.; Rifai, N.; Hu, F.B.; Rimm, E.B. Plasma adiponectin levels and risk of myocardial infarction in men. JAMA, 2004, 291, 1730-1737.
24. Rabin, K.R.; Kamari, Y.; Avni, I.; Grossman, E.; Sharabi, Y. Adiponectin; linking the metabolic syndrome to its cardiovascular consequences. Expert. Rev. Cardiovasc. Ther., 2005, 3, 465-471.
25. Tilg, H.; Moschen, A.R. Adipocytokines mediators linking adipose tissue, inflammation and immunity. Nat. Rev. Immunol, 2006, 6, 772-783.
26. Senolt, L.; Pavelka, K.; Hausa, D.; Haluzik, M. Increased adiponectin is negatively linked to the local inflammatory process in patients with RA. Cytokine, 2006, 35, 247-252.
27. Liu, C.J.; Chen, P.J.; Jeng, Y.M.; Huang, W.L.; Yang, W.S.; Lai, M.Y.; Kao, J.H.; Chen, D.S. Serum adiponectin correlates with viral characteristics but no histologic features in patients with chronic hepatitis C. J. Hepatol., 2005, 43(2), 235-242.
28. Yokota, T.; Meka, C.S.; Kouro, T.; Medina, K.L.; Igarashi, H.; Oritani, K.; Funahashi, T.; Tomiyama, Y.; Matsuzawa, Y.; Kincade, P.W. Adiponectin, a fat cell product influences the earliest lymphocytes precursors in bone marrow cultures by activation of the cyclooxygenase-prostaglandin pathway in stromal cells. J. Immunol., 2003, 171, 5091-5099.
29. Wolf, A.M.; Wolf, D.; Rumpold, H.; Enrich, B.; Tilg, H. Adiponectin induces the anti-inflammatory cytokines IL-10 and IL-1RA in human leucocytes. Biochem. Biophys. Res. Commun, 2004, 323, 630-635.
30. Maeda, N.; Shimomura, I.; Kishida, K.; Nishizawa, H.; Matsuda, M.; Nagaretani, H.; Furuyama, N.; Kondo, H.; Takahashi, M.; Arita, Y.; Komuro, R.; Ouchi, N.; Kihara, S.; Tochino, Y.; Okutomi, K.; Horie, M.; Takeda, S.; Aoyama, T.; Funahashi, T.; Matsuzawa, Y. Diet-induced insulin resistance in mice lacking adiponectin/ ACRP30. Nat. Med., 2002, 8, 731-737.
31. Ehling, A.; Schaffer, A.; Herfart, H.; Tarner, I.H.; Anders, S.; Distler, O.; Paul, G.; Distler, J.; Gay, S.; Schölmerich, J.; Neumann, H.; Müller-Ladner, U. The potential of adiponectin in driving arthritis. J. Immunol., 2006, 176, 4468-4478.
32. Otero, M.; Lago, R.; Gomez, R.; Dieguez, C.; Gomez-Reino, J.J.; Gualillo, O. Changes in plasma levels of fat-derived hormones adiponectin, leptin, resistin, and visfatin in patients with RA. Ann. Rheum. Dis., 2006, 65(9), 1198-1201.
33. Rovin, B.H.; Song, H.; Hebert, L.A.; Nadasdy, T.; Nadasdy, G.; Birmingham, D.J. Plasma, Urine and renal expression of adiponectin in human systemic lupus erythematosus. Kidney Int., 2005, 68, 1825-1833.
34. Brennan, F.M.; Maini, R.N.; Feldman, M. Cytokine expression in inflammatory diseases. Br. Med. Bull., 1995, 51, 368-384.
35. Zwahlen, R.; Walz, A.; Rot, A. In vitro and in vivo activity and pathophysiology of human IL-8 and related peptides. Int. Rev. Exp. Pathol., 1993, 34, 27-41.
36. Schattner, A.; Lachmi, V.; Livneh, A.; Pras, M.; Hahn, T. Tumor necrosis factor in familial mediterranean fever. Am. J. Med., 1991, 90, 434-438.
37. Mendall, M.A.; Patel, P.; Ballam, L.; Strachan, D.; Northfield, T.C. C-reactive protein and its relation to cardiovascular risk factors; a population based cross sectional study. BMJ, 1996, 312, 1061-1065.
38. Yang, W.S.; Lee, W.J.; Funahashi, T.; Tanaka, S.; Matsuzawa, Y.; Chao, C.L.; Chen, C.L.; Tai, T.Y.; Chuang, L.M. Weight reduction increases plasma levels of an adipose-derived anti-inflammatory protein, adiponectin. J. Clin. Endocrinol. Metab., 2001, 86(8), 3815-3819.
39. Anderson, P.D.; Mehta, N.N.; Wolfe, M.L.; Hinkle, C.C.; Pruscino, L.; Comiskey, L.L.; Tabita-Martinez, J.; Sellers, K.F.; Rickels, M.R.; Ahima, R.S.; Reilly, M.P. Innate immunity modulates adipokines in humans. J. Clin. Endocrinol. Metab., 2007, 92(6), 2272-2279.
40. Iwashima, Y.; Katsuya, T.; Ishikawa, K.; Ouchi, N.; Ohishi, M.; Sugimoto, K.; Fu, Y.; Motone, M.; Yamamoto, K.; Matsuo, A.; Ohashi, K.; Kihara, S.; Funahashi, T.; Rakugi, H.; Matsuzawa, Y.; Ogihara, T. Hypoadiponectinemia is an independent risk factor for hypertension. Hypertension, 2004, 43(6), 1318-1323.
41. Krakoff, J.; Funahashi, T.; Stehouver, C.D.; Schalkwick, G.C.; Tanaka, S.; Matsuzawa, Y.; Kobes, S.; Tataranni, P.A.; Hanson, R.L.; Knowler, W.C.; Lindsay, L.S. Inflammatory markers, adiponectin and risk of type 2 diabetes in the Pima Indian. Diabetes Care., 2003, 26(6), 657-662.
42. Schaffler, A.; Ehling, A.; Neumann, E.; Herfarth, H.; Tarner, I.; Scholmerich, J. Adipocytokines in synovial fluid. JAMA, 2003, 290, 1709-1710.
43. Blake, G.J.; Ridker, P.M. A novel clinical markers of vascular wall inflammation. Circ. Res., 2001, 89, 763-771.
44. Choi, K.M.; Ryu, O.H.; Lee, K.W.; Kim, H.Y.; Seo, J.A.; Kim, S.G.; Kim, N.H.; Choi, D.S.; Baik, S.H. Serum adiponectin, IL-10 levels and inflammatory markers in the metabolic syndrome. Diabetes Res. Clin. Pract., 2007, 75(2), 235-240.
45. Engeli, S.; Feldpausch, M.; Gorzelniak, K.; Hartwig, F.; Heintze, U.; Janke, J.; Möhlig, M.; Pfeiffer, A.F.; Luft, F.C.; Sharma, A.M. Association between adiponectin and mediators of inflammation in obese women. Diabetes, 2003, 52(4), 942-947.
46. Neumeier, M.; Weigert, J.; Schaffler, A.; Wehrwein, G.; Muller Ladner, U.; Scholmerich, J. Different effects of adiponectin isoforms in human monocytic cells. J. Leukoc. Biol., 2006, 79, 803-808.